Alberto Picca

Neuro-oncologist at @HopPitieSalpe, PhD candidate at @InstitutCerveau, bad footballer.
I don't like being taken too seriously.

[SiRIC CURAMUS @curamus]

📢 [Nouvelle publication] : résultats d'un essai thérapeutique explorant l’efficacité du traitement par fexagratinib dans un sous-type de gliome diffus

👉Pour en savoir plus : https://t.co/4IUYGIWSwg

@alberto_picca

[SiRIC CURAMUS @curamus]

📢 [OPEN REGISTRATIONS & CALL FOR ABSTRATCS] - Brain Tumor Microenvironment Symposium - 30th & 31st January 2025 - Paris

The SiRIC CURAMUS is delighted to organize its very first Brain Tumor Microenvironment Symposium !

👉 Program and registrations: https://t.co/otD1VZQYIr

[SiRIC CURAMUS @curamus]

📢 Only a few days left to register for the Oligodendroglioma Workshop that will take place the 20 & 21 september 2024 at the @InstitutCerveau in Paris, to mark the 15th anniversary of the POLA rare cancer network !
👇
https://t.co/JnjrLftyNn

[Luis J. Castro-Vega @LuisJaimeCastr3]

Happy to share our preprint! A big thank you to all the collaborators, co-authors, and everyone involved in this study. Feel free to contact us to discuss our findings; your scientific feedback is more than welcome. https://t.co/LkM1NJbA19

[Francesca Finotello @Francesca_Fin_]

📢New preprint alert: #Benchmarking second-generation methods for cell-type #deconvolution of #transcriptomic data

https://t.co/MhLf5Eo3yY

A thread 🧵👇

1/

[Brier Gallihugh, M.S @Brier_Gallihugh]

For those who check model assumptions (you ALL should), the {easystats} package makes it very easy to do this with various models but particularly regression models

[European Academy of Neurology @EANeurology]

Our congress always aims to reflect the interests and concerns of the neurology community, and your contributions play a huge part in helping to achieve that.

📆 Abstract submission deadline: Friday, 2 February
🔗 Learn more: https://t.co/0AALkW0yw7

#EAN2024 #EANeurology

[EANO @EANOassociation]

#RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade #Gliomas in Adults https://t.co/u0YD0cp8Mv
#btsm #neuroradiology @JCO_ASCO

[The Nobel Prize @NobelPrize]

Marie Curie died of aplastic anaemia on 4 July 1934, a result of years of exposure to radiation through her work. Even today her laboratory notebook from 1899-1902, is radioactive and will be for 1,500 years.

[EANO @EANOassociation]

Each year on June 8, #WorldBrainTumorDay is observed to raise awareness & educate people about brain tumors. EANO is dedicated to promote advances in #NeuroOncology through innovative research & concerted education & training. Together, we can make a difference! #btsm @OncoAlert

[EANO @EANOassociation]

#Vorasidenib in IDH1- or IDH2-Mutant Low-Grade #Glioma | NEJM.
https://t.co/sk7S8yLNL8
#btsm #idh @NEJM

[EANO @EANOassociation]

If you're looking for the next opportunity to advance your #NeuroOncology education, plan to attend #EANO2023 in Rotterdam, NL. Get the latest information on #NeuroSurgery #Neuropathology #braintumor #Neuroimaging #Immunotherapy et al. Learn more https://t.co/GAXM4I2R7M #btsm

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Dynamics and specificities of T cells in cancer immunotherapy https://t.co/xaJOg5isQJ

[EANO @EANOassociation]

🚨Today, April 12 at 23:59 hrs CEST is the very last day to submit your abstract for #EANO2023. We’re very excited to see so many submissions & are looking forward to your presentations!
https://t.co/kJ4wk0HMLW
#NeuroOncology #btsm @OncoAlert @theIBTA @EuropeanCancer @NeuroOnc

[Nature Medicine @NatureMedicine]

@michelle_monje Crystal Mackall & colleagues describe a localized toxicity syndrome associated with #immunotherapy treatment for CNS tumors, and propose a new grading scale to help standardize reporting and promote research.
@StanfordMed #CARTtherapy
https://t.co/Ah1qYWkEYj

[Nature Cancer @NatureCancer]

✨DON’T MISS THIS @NatureCancer PERSPECTIVE – “Targeting public neoantigens for cancer immunotherapy” #ShibinZhou & Co.
Find it here👇

https://t.co/afspQLMm23
https://t.co/lyJkvTmKGB

[EANO @EANOassociation]

🚨 Still working on your abstract submission for #EANO2023? Don’t panic: The submission deadline has been extended until April 12, 23:59 CEST. 👉https://t.co/oszuKWwwp6… #neurosurgery #NeuroOncology #btsm @OncoAlert @theIBTA @EuropeanCancer @EditorNeuro @BNOSofficial @GrupoGeino

[EANO @EANOassociation]

#NeuroOncology Youngsters! Take an active part to share knowledge & make progress for patients with brain tumors. Submit your abstract to #EANO2023 by April 6, 2023 at 23:59 hrs CEST 👉https://t.co/kJ4wk0HMLW #btsm #neurosurgery #glioma #Immunotherapy #pathophysiology @OncoAlert

[DrJE-Salem @DrJESalem]

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy https://t.co/bXY0o1xegH